Fundraising FoxPhase Two Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Navega Therapeuticsnavegatx.cominJan 2026
Navega Therapeutics develops gene therapies using zinc-finger and CRISPR-based epigenome regulation to control gene expression.
BiotechDeep TechHealthtechSan Diego, US
Fernando Aleman(Executive Officer, Director)inAna Moreno(Executive Officer, Director)inRandy Socol(Executive Officer)
Co-investorsBioBrit
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.